Profile
BIOC DHR-PB TMO DHR IDXX A
Company Name Biocept, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $450.79K $916.76B $184.93B $151.04B $51.27B $33.86B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Darrell Taylor Rainer M. Blair Marc N. Casper Rainer M. Blair Jonathan J. Mazelsky Padraig McDonnell
Ratings
BIOC DHR-PB TMO DHR IDXX A
Quant Rating Score 4 5 3 3 3 4
Quant Rating Buy Strong Buy Neutral Neutral Neutral Buy
Trading
BIOC DHR-PB TMO DHR IDXX A
Last Close $0.4349 $1261.26 $489.74 $205.29 $647.03 $124.96
High 52 $0.43 $1261.26 $624.21 $278.02 $682.78 $152.6
Low 52 $0.43 $1261.26 $390.2 $174.64 $361.04 $99.29
Price vs. 52 Week High 1.14 % 0 % -21.54 % -26.16 % -5.24 % -18.11 %
Price vs. 52 Week Low 1.14 % 0 % 25.51 % 17.55 % 79.21 % 25.85 %
Total Return
BIOC DHR-PB TMO DHR IDXX A
1 Month Return 0 % 0 % 1.56 % -0.75 % 12.91 % 4.27 %
3 Month Return 0 % 0 % 21.3 % 7.78 % 25.5 % 10.31 %
6 Month Return 0 % 0 % -7.41 % -1.19 % 48.02 % -2.31 %
9 Month Return 0 % 0 % -7.53 % -14.35 % 53.42 % -9.43 %
YTD Return 0 % 0 % -5.86 % -10.57 % 56.5 % -6.98 %
1 Year Return 0 % 0 % -19.94 % -23.12 % 32.78 % -12.33 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIOC DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.58 % 0.33 % 0.56 % - 0.82 %
Dividend Paid and Capex Coverage Ration (TTM) -16.47 % 2.91 % 3.76 % 2.91 % 6.89 % 2.36 %
Dividend Per Share (TTM) - 1.18 % 1.64 % 1.18 % - 0.98 %
Payout Ratio (TTM) - 23.85 % 9.26 % 23.85 % - 23.76 %
Growth
BIOC DHR-PB TMO DHR IDXX A
Asset Growth -48.9 % -8.22 % -1.42 % -8.22 % 1.03 % 10.06 %
Gross Profit Growth -110.99 % 1.23 % 3.44 % 1.23 % 8.63 % 2.02 %
Revenue Growth -57.78 % -0.06 % 0.05 % -0.06 % 6.46 % -4.73 %
Revenue 3 Year -43.02 % -20.76 % 12.79 % -20.76 % 25.23 % -1.99 %
Revenue 5 Year -97.24 % 30.38 % 75.79 % 30.38 % 69.09 % 29.92 %
Revenue 10 Year -93.01 % 15.17 % 164.64 % 15.17 % 218.38 % 85.12 %
EBIT Growth - -7.62 % 13.28 % -7.62 % 3.47 % 12.76 %
Net Income Growth -1036.23 % -18.16 % 5.67 % -18.16 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share 84.12 % -40.75 % -15.42 % -40.75 % 23.15 % 5.98 %
Net Income 5 Yeari Growth Per Share 99.2 % 26.78 % 79.48 % 26.78 % 116.76 % 91.02 %
Net Income 10 Yeari Growth Per Share 99.92 % 44.14 % 248.59 % 44.14 % 492.42 % 269.11 %
Operating Income Growth -1227.65 % -6.52 % 6.97 % -6.52 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -460.14 % -6.64 % 3.1 % -6.64 % 2.48 % -1.19 %
Operating 3 Year CFG 92.98 % -21.78 % -6.33 % -21.78 % 27.03 % 37.6 %
Operating 5 Year CFG 99.63 % 65.54 % 82.49 % 65.54 % 111.28 % 102.58 %
Operating 10 Year CFG 99.95 % 70.94 % 244.88 % 70.94 % 378.1 % 309.5 %
EPS Growth -890.92 % -17.24 % 6.76 % -17.24 % 5.9 % 5.21 %
EPS Diluted Growth -890.92 % -17.08 % 6.99 % -17.08 % 6.06 % 5.73 %
Book Value Per Share -79.4 % -6.67 % 7.15 % -6.67 % 8.24 % 2.3 %
Share Holder 3 Year Equity Growth Per Share -90.36 % 7.23 % 25.29 % 7.23 % 138.87 % 14.63 %
Share Holder 5 Year Equity Growth Per Share -96.3 % 60.08 % 74.85 % 60.08 % 838.67 % 28.96 %
Share Holder 10 Year Equity Growth Per Share 100.01 % 103.57 % 151.37 % 103.57 % 1547.69 % 63 %
Dividend Per Share Growth - -5.75 % 12.64 % -5.75 % - 4.82 %
Dividend 3 Year Growth Per Share - 1.18 % 52.23 % 1.18 % - 13 %
Dividend 5 Year Growth Per Share - 42.62 % 105.55 % 42.62 % - 31.51 %
Dividend 10 Year Growth Per Share - 224 % 158.83 % 224 % - 136.56 %
Debt Growth -4.45 % -18.07 % -10.43 % -18.07 % -7.53 % 23.28 %
Free Cash Flow Growth -765.53 % -8.39 % 4.91 % -8.39 % 3.26 % -6.85 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
BIOC DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM -9.99 % 61.52 % 39.58 % 61.52 % 61.54 % 53.35 %
Return on Assets TTM -103.93 % 4.18 % 6.5 % 4.18 % 29.59 % 9.59 %
Return on Equity TTM -138.49 % 6.69 % 13.27 % 6.69 % 64.42 % 19.46 %
Return on Capital Employed TTM -126.08 % 6.93 % 8.97 % 6.93 % 59.57 % 13.97 %
Net Income Per EBT TTM 99.61 % 83.73 % 93.8 % 83.73 % 80.28 % 85.05 %
EBT Per Ebit TTM 100.72 % 78.61 % 88.39 % 78.61 % 97.81 % 96.75 %
EBIT Per Revenue TTM -123.69 % 21.59 % 18.38 % 21.59 % 31.09 % 21.38 %
Cash Flow To Debt Ratio TTM -109.74 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Receivables Turnover TTM 12.02 5.32 4.31 5.32 6.09 4.85
Payables Turnover TTM 18.67 5.36 8.76 5.36 13.32 5.98
Inventory Turnover TTM 37.57 3.44 4.7 3.44 3.96 3.12
Fixed Asset Turnover TTM 182.82 % 374.68 % 448.49 % 374.68 % 464.4 % 346.65 %
Asset Turnover TTM 83.76 % 29.42 % 42.69 % 29.42 % 121.22 % 54.52 %
Operating Cash Flow Per Share TTM -23.52 8.61 20.05 8.61 11.26 5.56
Free Cash Flow Per Share TTM -24.94 6.79 16.32 6.79 9.63 4.17
Cash Per Share TTM 2282.14 % 412.7 % 1690.48 % 412.7 % 204.69 % 521.4 %
Operating Cash Flow Sales Ratio TTM -51.39 % 25.69 % 17.54 % 25.69 % 22.43 % 23.91 %
Free Cash Flow Operating Cash Flow Ratio TTM 106.07 % 78.81 % 81.42 % 78.81 % 85.49 % 75.02 %
Cash Flow Coverage Ratios TTM -109.74 % 33.25 % 21.51 % 33.25 % 73.21 % 45.35 %
Price To Free Cash Flows Ratio TTM -0.03 30.19 29.97 31.06 66.21 28.48
Price To Operating Cash Flows Ratio TTM -0.02 23.81 24.43 24.5 56.89 21.43
Price Cash Flow Ratio TTM -0.02 23.81 24.43 24.5 56.89 21.43
Income Statement (TTM)
BIOC DHR-PB TMO DHR IDXX A
Revenue $0.03B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $-0B $14.21B $17.73B $14.21B $2.38B $3.54B
Gross Profit Ratio -9.99% 59.5% 41.34% 59.5% 61.04% 54.3%
EBITDA $-0.03B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -56.78 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
BIOC DHR-PB TMO DHR IDXX A
Long Term Debt $0.01B $16.47B $30.3B $16.47B $0.55B $3.49B
Total Liabilities $0.02B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $1.82B $2.12B $1.82B $0.06B $0.18B
Total Debt $0.01B $17.15B $32.78B $17.15B $0.99B $3.57B
Total Assets $0.03B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
BIOC DHR-PB TMO DHR IDXX A
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $-0.03B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 125.74
ACRS Aclaris Therapeutics, Inc. 1.925
ADVB Advanced Biomed Inc. Common Stock 0.4432
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 3.22
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.4294
BIAF bioAffinity Technologies, Inc. 0.2472
BIAFW bioAffinity Technologies, Inc. 0.07
BNGO Bionano Genomics, Inc. 3.77
BNGOW BioNano Genomics, Inc. WT EXP 082123 0.0036
BNR Burning Rock Biotech Limited 8.69
CDNA CareDx, Inc 13.66
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.7605
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 163.35
CSTL Castle Biosciences, Inc. 24.03
DGX Quest Diagnostics Incorporated 181.69
ETFs With Exposure to BIOC
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 141.32
Unlock